Subpleural reticulation is a pattern seen on lung CT scans in which a network of fine, interlocking lines appears in the outer edges of the lungs, just beneath the membrane that covers them. It represents thickening of the tissue between the lung’s tiny air sacs, and its presence often signals some degree of scarring or early fibrotic change. The pattern can show up in a range of conditions, from idiopathic pulmonary fibrosis to autoimmune diseases to asbestos exposure, and its significance depends heavily on context: what else the scan shows, the patient’s history, and whether the pattern changes over time.
What It Looks Like on a CT Scan
On a high-resolution CT (HRCT) scan, subpleural reticulation appears as a meshwork of thin white lines concentrated in the outermost portion of the lung tissue, closest to the chest wall. Radiologists sometimes describe it as resembling a fine net draped along the lung surface. The lines represent walls between air sacs that have become abnormally thickened by inflammation, fluid, or scar tissue. Because CT scans show cross-sectional slices of the chest, the pattern typically stands out as irregular lines that interconnect with one another, distinct from the smooth, uniform appearance of healthy lung.
The “subpleural” part of the term matters. It tells you the reticulation favors the periphery of the lung rather than the central airways. This location is a hallmark of certain diseases, particularly usual interstitial pneumonia (UIP), the pattern most associated with idiopathic pulmonary fibrosis. In UIP, subpleural reticulation tends to predominate in the lower lobes and at the bases of the lungs, with a gradient from mild changes at the top to more severe involvement at the bottom.
Conditions That Produce Subpleural Reticulation
Several diseases can cause this pattern, and distinguishing among them is one of the core challenges in chest radiology. The conditions share a tendency to injure and scar the lung’s delicate framework, but they differ in cause, pace, and accompanying features on the scan.
Idiopathic Pulmonary Fibrosis
IPF is the most widely recognized condition linked to subpleural reticulation. Its imaging hallmark is the UIP pattern, characterized by subpleural reticulation alongside traction bronchiectasis (airways stretched open by surrounding scar tissue) and, in advanced disease, honeycombing, which refers to clusters of thick-walled cysts that give the lung a honeycomb-like appearance.1European Society of Radiology. Idiopathic Pulmonary Fibrosis and mimics: A practical guide for general radiologists IPF overwhelmingly affects the lower lobes and the lung periphery. About half of patients with IPF have HRCT findings typical enough to allow a confident diagnosis from imaging alone, while the other half show atypical patterns that overlap with other diseases.2American Journal of Roentgenology. Idiopathic pulmonary fibrosis: spectrum of high-resolution CT findings
Connective Tissue Diseases
Autoimmune conditions can inflame the lung in ways that produce reticulation. Polymyositis and dermatomyositis (inflammatory muscle diseases) are particularly associated with prominent reticulation and consolidation on CT. By contrast, rheumatoid arthritis tends to produce reticulation less frequently, even though it commonly affects the lungs in other ways.3PubMed Central. A comparative study of different types of connective tissue-associated interstitial lung disease The scan pattern in autoimmune-related lung disease can closely mimic IPF, which is one reason doctors look carefully at blood tests and clinical symptoms before settling on a diagnosis.
Asbestos Exposure
Asbestosis, the scarring caused by inhaled asbestos fibers, also produces subpleural changes, but they tend to look somewhat different from IPF. A comparative study found that asbestosis patients more frequently showed subpleural dot-like or branching opacities, subpleural curvilinear lines, and parenchymal bands compared with IPF patients.4PubMed. High-resolution CT of asbestosis and idiopathic pulmonary fibrosis Pleural plaques, which are calcified patches on the lining of the chest wall, also point strongly toward asbestos as the underlying cause. If you have a known occupational history involving asbestos and your CT shows subpleural reticulation, this context will weigh heavily in interpretation.
Hypersensitivity Pneumonitis
Hypersensitivity pneumonitis (HP) develops from repeated inhalation of organic dusts or chemicals, such as mold spores, bird droppings, or certain industrial compounds. In its chronic form, HP produces reticulation on CT as fibrosis layers on top of the earlier inflammatory changes.5PubMed. Hypersensitivity pneumonitis: spectrum of high-resolution CT and pathologic findings Unlike IPF, chronic HP often involves the mid-lung zones or shows a mosaic pattern of mixed density, which can help radiologists differentiate the two. When reticulation in chronic HP appears alongside traction bronchiectasis and honeycomb cysts, the fibrotic changes are considered irreversible.6PubMed Central. Characteristics of irreversibility in high-resolution computed tomography in chronic hypersensitivity pneumonitis
Drug-Induced Lung Injury
Certain medications can damage the lungs in ways that produce interstitial patterns on imaging. Methotrexate, commonly prescribed for rheumatoid arthritis and other autoimmune conditions, causes pulmonary toxicity in roughly 7% of patients on chronic therapy. The most common presentation is hypersensitivity pneumonitis, though the drug can also trigger organizing pneumonia or frank pulmonary fibrosis.7PubMed Central. HRCT Patterns of Drug-Induced Interstitial Lung Diseases: A Review Chemotherapy agents, certain heart drugs, and some antibiotics are other known culprits. When subpleural reticulation appears in someone taking a medication with known lung toxicity, stopping or switching the drug is often the first step.
When Reticulation Signals Progressive Disease
One of the most important questions about subpleural reticulation is whether it will stay stable or worsen. Not every instance of fine lines on a CT scan means progressive lung scarring, but certain features raise the likelihood considerably.
A large study examining over 155,000 individuals found that about 2% had interstitial lung abnormalities (ILAs), which are early, often incidental CT findings that include ground-glass opacity and reticulation in people without a known lung disease diagnosis. Among those with the most common subtype, subpleural nonfibrotic ILAs, about 44% showed radiological progression over four years. The presence of reticulation on the initial scan roughly doubled the odds of progression, even after accounting for other factors.8American Journal of Respiratory and Critical Care Medicine. Reticulation Is a Risk Factor of Progressive Subpleural Nonfibrotic Interstitial Lung Abnormalities Strikingly, when reticulation was extensive, the rate of progression was comparable to that seen in already-fibrotic ILAs, suggesting that heavy reticulation in an otherwise nonfibrotic picture may be a bridge toward more advanced scarring.
A separate study looking specifically at patients with established interstitial lung disease found that a high extent of reticulation on CT (even without honeycombing) tripled the odds of disease progression.9PubMed Central. Reticulation pattern without honeycombing on high-resolution CT is associated with the risk of disease progression in interstitial lung diseases This is clinically significant because honeycombing has traditionally been the red flag for severe fibrosis, while reticulation alone was sometimes viewed as less concerning. The evidence suggests that widespread reticulation without honeycombing still warrants close monitoring.
How Reticulation Differs From Other CT Patterns
If you have seen the terms “ground-glass opacity,” “honeycombing,” and “reticulation” used in the same radiology report, it helps to understand what each one represents and how they relate to one another.
Ground-glass opacity is a hazy increase in lung density through which the normal lung structures (blood vessels and airways) can still be seen. It usually reflects active inflammation or fluid in the air sacs, not established scarring. It can be reversible if the underlying cause is treated. Reticulation, by contrast, generally reflects structural changes in the tissue between air sacs. When both appear together, it often means there is a mix of active inflammation and early fibrosis. In IPF specifically, reticulation predominates, while ground-glass opacity may be relatively mild. When ground-glass changes dominate instead, the diagnosis may lean toward a different condition, such as nonspecific interstitial pneumonia or organizing pneumonia.2American Journal of Roentgenology. Idiopathic pulmonary fibrosis: spectrum of high-resolution CT findings
Honeycombing represents a more advanced stage of fibrosis. It appears as stacked, thick-walled cysts, typically in the same subpleural distribution where reticulation is seen. In fibrotic diseases like IPF and chronic HP, the progression often runs from reticulation to traction bronchiectasis to honeycombing over months or years, though not every patient follows this sequence neatly. In chronic HP, a fibrosis score combining the extent of reticulation and honeycombing is used to track how much irreversible damage has accumulated.10PubMed. Serial changes of CT findings in patients with chronic hypersensitivity pneumonitis: imaging trajectories and predictors of fibrotic progression and acute exacerbation
Age-Related Changes That Can Mimic Reticulation
Here is a wrinkle that catches many people off guard: some degree of subpleural reticulation on CT may simply reflect aging lungs. A study comparing CT scans of people over 75 with those under 55 found a limited subpleural reticular pattern in 60% of the older group and in none of the younger group.11PubMed. Lung morphology in the elderly: comparative CT study of subjects over 75 years old versus those under 55 years old These changes were mild, tended to stay at the lung bases, and did not necessarily mean the person had a progressive lung disease.
Gravity also plays a role in creating false alarms. When you lie on your back for a CT scan, the weight of the lungs compresses the tissue at the back (the dependent portions), which can create the appearance of subpleural opacities that are not truly there. One way radiologists handle this is by performing a prone CT, where you lie face down, which redistributes the compression. Research shows that for nonfibrotic interstitial lung abnormalities, prone scanning significantly improves both detection accuracy and agreement among radiologists reading the scans.12PubMed Central. Optimizing prone CT use for suspected interstitial lung abnormalities If your initial CT shows mild subpleural reticulation at the lung bases and your doctor is unsure whether it is real or gravity-dependent, a prone scan can help clarify things.
Diagnosis Beyond Imaging
A CT scan can identify the pattern, but pinning down the cause usually requires more than imaging alone. In practice, interstitial lung diseases are diagnosed through a multidisciplinary process involving pulmonologists, radiologists, and often pathologists working together.
Blood tests play a supporting role. A biomarker called KL-6, a protein released by damaged lung cells, has shown promise for monitoring patients with interstitial lung abnormalities. In one study, a KL-6 level above 400 U/mL was independently associated with radiological progression, with odds more than eight times higher than in patients with lower levels.13Tuberculosis and Respiratory Diseases. Serum Krebs von den Lungen-6 Level as a Reflecting Biomarker in Patients with Interstitial Lung Abnormalities KL-6 is not specific enough to diagnose a particular disease, but it can help clinicians decide whether to watch and wait or pursue further testing. Other blood work, including autoimmune panels, is routinely drawn to check for connective tissue diseases.
When imaging and blood tests leave the diagnosis uncertain, a lung biopsy may be considered. Transbronchial cryobiopsy, a less invasive alternative to surgical lung biopsy, has gained ground in recent years. Evidence suggests it is safer than surgical biopsy and contributes comparably to the diagnosis when results are discussed in a multidisciplinary setting, although the tissue samples are smaller and the diagnostic yield is somewhat lower, around 80% compared with 95% for surgical biopsy.14Chest. Transbronchial Cryobiopsy for the Diagnosis of Interstitial Lung Diseases: CHEST Guideline and Expert Panel Report For many patients, the reduced risk makes it an attractive first step before considering surgery.
Treatment When Fibrosis Is Progressing
If subpleural reticulation turns out to represent progressive fibrosis, treatment options depend on the underlying diagnosis. For IPF, the two approved antifibrotic drugs, pirfenidone and nintedanib, have been shown to slow the decline in lung function, as measured by forced vital capacity (the amount of air you can forcefully exhale). These same drugs have also shown benefit in other fibrotic interstitial lung diseases beyond IPF. The most common side effects are gastrointestinal, including diarrhea and nausea, along with skin sensitivity to sunlight, particularly with pirfenidone.15PubMed Central. Pirfenidone and Nintedanib in Pulmonary Fibrosis: Lights and Shadows Neither drug reverses existing scarring; the goal is to slow the rate at which scarring accumulates. This is why early detection of progressive reticulation matters so much.
When autoimmune disease is the underlying cause, immunosuppressive therapy targeting the immune system’s overactivity is typically the first-line approach, sometimes combined with antifibrotic treatment if fibrosis is progressing despite immune control. For hypersensitivity pneumonitis, removing the environmental trigger (the mold, the bird, the chemical) is essential and can halt progression in some cases, though established fibrosis typically does not reverse. For drug-induced lung disease, stopping the offending medication is the primary intervention.
Genetic Factors Behind Lung Fibrosis
Not everyone exposed to the same triggers develops fibrosis, which has led researchers to investigate genetic susceptibility. The strongest known genetic risk factor for IPF is a variant in the MUC5B gene, which codes for a mucus protein in the airways. Other contributors include genes involved in maintaining telomeres (the protective caps on chromosomes) and genes for surfactant proteins, which help keep the lung’s air sacs from collapsing.16PubMed Central. Genetic Determinants of Progressive Pulmonary Fibrosis: A Comprehensive Review Shortened telomeres are found in a subset of pulmonary fibrosis patients and are associated with familial forms of the disease, where multiple family members develop lung scarring.
These genetic findings do not currently change how subpleural reticulation is managed for most patients. You would not be offered a genetic test just because mild reticulation appeared on your scan. But in families where multiple members have been diagnosed with pulmonary fibrosis, or in younger patients with unexplained fibrosis, genetic testing can clarify the diagnosis and influence treatment decisions, particularly around lung transplant planning and monitoring of at-risk relatives.
When Subpleural Reticulation Is Found Incidentally
A common scenario is the accidental discovery of subpleural reticulation on a CT scan done for an entirely different reason, such as screening for lung cancer or evaluating chest pain. This is increasingly frequent as CT scanning becomes more routine. These incidental interstitial lung abnormalities are found in roughly 2 to 10% of people scanned, depending on the population studied and how strictly the findings are defined.
If this happens to you, it does not automatically mean you have a progressive lung disease. Many of these findings remain stable over time, particularly when they are mild and not accompanied by other worrisome features like traction bronchiectasis or honeycombing. The factors that most strongly predict progression include the extent of reticulation at baseline, the presence of accompanying fibrotic features, older age, and elevated biomarkers like KL-6.8American Journal of Respiratory and Critical Care Medicine. Reticulation Is a Risk Factor of Progressive Subpleural Nonfibrotic Interstitial Lung Abnormalities Current practice often involves a follow-up CT scan in 12 to 24 months to check for change, along with baseline lung function tests. If the pattern is stable and you have no symptoms, ongoing monitoring at wider intervals may be all that is needed. If progression is detected, referral to a pulmonologist with expertise in interstitial lung disease is the standard next step.